Merck now has global rights to a SciBrunch Therapeutics drug candidate designed to block mutated versions of the ...

Affordability is top of mind for executives at AHIP as Americans battle skyrocketing healthcare costs. “We are laser-focused on affordability at AHIP,” said Mike Tuffin, president and CEO of AHIP.

Mirum Pharmaceuticals’ Atebrioz is the third FDA-approved drug for fibrodysplasia ossificans progressiva (FOP), but it brings ...

Pelago launched a behavioral health platform that integrates substance use, mental health and behavioral addiction care, ...

When drug prices are too high for patients, physicians take on additional workload to find solutions. A newly released 2026 ...

As AI technology in healthcare becomes more deeply involved in the complex, high-stakes tasks of diagnosis and treatment ...

Hospitals' operating margins fell to 1.4% in July, down from 2.2% in May and June, according to new data from Kaufman Hall.

As Medicare Advantage denial rates climb, health systems are dropping plans and steering patients back to traditional ...

Novartis is acquiring a Sironax platform technology designed to transport a range of drug modalities across the protective ...

Healthcare leaders know how to test software. We don't yet have a shared playbook for onboarding agents expected to do a job ...

The next evolution in ADHD therapy needs to focus not only on drug efficacy but also on how treatment aligns with the ...

CertifyOS launched a shared credentialing program that allows providers to submit their information once for multiple health ...